AI-driven precision wellness empowers proactive health choices through genomics, digital twins, and predictive insights—reshaping medicine from reactive to preventative ...

Kim’s death, which police consider a suicide, adds to a growing list of high-profile celebrity deaths in the country, which ...

Doctors are hoping a clinical trial at Harris Health Ben Taub will prove the treatment works and it’s worth getting ...

President Trump signed an executive order that seeks to expand access to in-vitro fertilization and make it more affordable.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chemomab Therapeutics (CMMB – Research Report) ...

At the State of Black Health second annual summit hosted by BlackDoctor.org in partnership with USA TODAY, corporate leaders ...

If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...

Keytruda, a cancer-immunotherapy medicine, ranks among the most lucrative drugs ever sold. Since its launch in 2014 it has raked in over $130bn in sales for Merck, its American maker, including $ ...

Iron Mountain purchased an undeveloped 66-acre site from Henrico’s Economic Development Authority in November and plans to build a complex at 6110 Technology Creek Drive, the authority said Tuesday.

Needham & Company LLC restated a “buy” rating and set a $133.00 target price on shares of Blueprint Medicines in a report on Thursday. HC Wainwright restated a “buy” rating and set a $135. ...

Silence Therapeutics has launched legal action alleging that late stage drugs from rivals Alnylam and The Medicines Company infringe its intellectual property. Silence, which specialises in ...